Daniel Robert Hostetter

Person

Palo Alto, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 11,884,746
- Issue date Jan 30, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloproteinase substrates and other cleavable moieties an...
- Patent number 11,814,410
- Issue date Nov 14, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 ant...
- Patent number 11,802,158
- Issue date Oct 31, 2023
- Cytomx Therapeutics, Inc.
- Bryan Allen Irving
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,944
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,943
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,472,875
- Issue date Oct 18, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 11,174,316
- Issue date Nov 16, 2021
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies, multispecific activatable antibodies and...
- Patent number 11,161,906
- Issue date Nov 2, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,046,759
- Issue date Jun 29, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 11,028,126
- Issue date Jun 8, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 ant...
- Patent number 10,669,337
- Issue date Jun 2, 2020
- CytomX Therapeutics, Inc.
- Bryan Allen Irving
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 10,669,339
- Issue date Jun 2, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind interleukin-6 receptor and methods...
- Patent number 10,611,845
- Issue date Apr 7, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 10,336,824
- Issue date Jul 2, 2019
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for urokinase-type plasminogen activator and me...
- Patent number 10,239,954
- Issue date Mar 26, 2019
- The Regents of the University of California
- Natalia Sevillano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 10,138,272
- Issue date Nov 27, 2018
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for urokinase-type plasminogen activator and me...
- Patent number 9,695,249
- Issue date Jul 4, 2017
- The Regents of the University of California
- Natalia Sevillano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 9,562,073
- Issue date Feb 7, 2017
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind interleukin-6 receptor and methods...
- Patent number 9,487,590
- Issue date Nov 8, 2016
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for urokinase-type plasminogen activator and me...
- Patent number 9,255,155
- Issue date Feb 9, 2016
- The Regents of the University of California
- Natalia Sevillano
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20240150402
- Publication date May 9, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20240150478
- Publication date May 9, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20240084022
- Publication date Mar 14, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANT...
- Publication number 20240084010
- Publication date Mar 14, 2024
- CytomX Therapeutics, Inc.
- Bryan Allen Irving
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION
- Publication number 20230331841
- Publication date Oct 19, 2023
- CRISPR Therapeutics AG
- Daniel Robert HOSTETTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230212283
- Publication date Jul 6, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY ENGINEERED IMMUNE CELLS HAVING A DISRUPTED CD83 GENE
- Publication number 20230128917
- Publication date Apr 27, 2023
- CRISPR Therapeutics AG
- Daniel Robert Hostetter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230021301
- Publication date Jan 19, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20220411470
- Publication date Dec 29, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20220380453
- Publication date Dec 1, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20220298245
- Publication date Sep 22, 2022
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20210355208
- Publication date Nov 18, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20210347886
- Publication date Nov 11, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND...
- Publication number 20210238291
- Publication date Aug 5, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANT...
- Publication number 20210047406
- Publication date Feb 18, 2021
- CytomX Therapeutics, Inc.
- Bryan Allen Irving
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...
- Publication number 20200339694
- Publication date Oct 29, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20200231677
- Publication date Jul 23, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20190382493
- Publication date Dec 19, 2019
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20190284283
- Publication date Sep 19, 2019
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20190241652
- Publication date Aug 8, 2019
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20190135864
- Publication date May 9, 2019
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Specific for Urokinase-Type Plasminogen Activator and Me...
- Publication number 20170335012
- Publication date Nov 23, 2017
- The Regents of the University of California
- Natalia Sevillano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20170204139
- Publication date Jul 20, 2017
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...
- Publication number 20170002082
- Publication date Jan 5, 2017
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20160311903
- Publication date Oct 27, 2016
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20160289324
- Publication date Oct 6, 2016
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Specific for Urokinase-Type Plasminogen Activator and Me...
- Publication number 20160215064
- Publication date Jul 28, 2016
- CytomX Therapeutics, Inc.
- Natalia Sevillano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD3 ANTIBODIES, ACTIVATABLE ANTI-CD3 ANTIBODIES, MULTISPECIFIC...
- Publication number 20160194399
- Publication date Jul 7, 2016
- CytomX Therapeutics, Inc.
- Bryan Allen Irving
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20150218217
- Publication date Aug 6, 2015
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Matrix Metalloproteinase Substrates And Other Cleavable Moieties An...
- Publication number 20150087810
- Publication date Mar 26, 2015
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY

Daniel Robert Hostetter

Person

Patents Grantslast 30 patents

Matriptase and u-plasminogen activator substrates and other cleavab...

Matrix metalloproteinase substrates and other cleavable moieties an...

Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 ant...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Multispecific antibodies, multispecific activatable antibodies and...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matriptase and u-plasminogen activator substrates and other cleavab...

Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 ant...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Activatable antibodies that bind interleukin-6 receptor and methods...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Antibodies specific for urokinase-type plasminogen activator and me...

Matriptase and u-plasminogen activator substrates and other cleavab...

Antibodies specific for urokinase-type plasminogen activator and me...

Matriptase and u-plasminogen activator substrates and other cleavab...

Activatable antibodies that bind interleukin-6 receptor and methods...

Antibodies specific for urokinase-type plasminogen activator and me...

Patents Applicationslast 30 patents

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANT...

ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

GENETICALLY ENGINEERED IMMUNE CELLS HAVING A DISRUPTED CD83 GENE

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND...

BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANT...

ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

Antibodies Specific for Urokinase-Type Plasminogen Activator and Me...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

Antibodies Specific for Urokinase-Type Plasminogen Activator and Me...

ANTI-CD3 ANTIBODIES, ACTIVATABLE ANTI-CD3 ANTIBODIES, MULTISPECIFIC...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

Matrix Metalloproteinase Substrates And Other Cleavable Moieties An...